For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250730:nRSd0727Ta&default-theme=true
RNS Number : 0727T Optima Health PLC 30 July 2025
Optima Health plc
("Optima", the "Company", and, together with its subsidiaries, the "Group")
Notice of Annual General Meeting and posting of Annual Report
LONDON, UK, 30 July 2025, Optima Health (AIM: OPT), the UK's leading provider
of technology enabled corporate health and wellbeing solutions, announces that
the Notice of Annual General Meeting ("AGM") together with a copy of the 2025
Annual report and accounts are being sent to shareholders today. These
documents will be made available shortly on the "Investors" section of the
Group's website at www.optimahealth.co.uk (http://www.optimahealth.co.uk/) .
The Company intends to hold its AGM on Monday 1 September 2025 at its offices
at Cornerblock, 5th Floor, 11 Quay Street, Manchester, M3 3HN, commencing at
12pm BST.
Enquiries
Optima Health +44(0)3300085113
Jonathan Thomas, CEO media@OptimaHealth.co.uk
Heidi Giles, CFO
Nominated Adviser and Corporate Broker
Panmure Liberum Limited +44 (0)20 3100 2000
Emma Earl / Will Goode/ Mark Rogers
Rupert Dearden
UK Financial PR Adviser optimahealth@icrinc.com
ICR Healthcare
Mary-Jane Elliott / Angela Gray / Lindsey Neville
About Optima Health
Optima Health is the UK's leading provider of occupational health and
wellbeing services, directly influencing and improving people's lives for 25
years. Optima Health's incredible team of professionals quickly and
effectively encapsulate client's needs, supporting organisations of all shapes
and sizes. Through tailored solutions and innovative systems, Optima Health
offers unparalleled clinical expertise to its clients. These solutions ensure
that processes are simple and allow its clients to spend more time focusing on
their employees driving a healthy, high-performing workplace. For more
information visit www.optima health.co.uk
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END NOARLMFTMTITBBA